A chronic signaling TGFb zebrafish reporter identifies immune response in melanoma
ChIP-seq / ATAC-seq (genome binding and open chromatin) · zebrafish · 40 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Danio rerio (zebrafish)
- Topic
- MelanomaThis series is part of our curated briefing on it.
- Samples
- 40 samples: 7 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE213360_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA880593 and SRA study SRP397063. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 26 samples read as cases, 8 as controls.
How we read this: 7 replicated groups read from 40 sample titles; they account for 21 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6578998 Vehicle Control A375 INPUT 6.11.18
- GSM6578999 TGFB1 stimulated A375 INPUT 6.11.18
- GSM6579000 Vehicle Control A375 H3K27ac 6.11.18
- GSM6579001 Vehicle Control A375 Smad2/3 6.11.18
- GSM6579002 TGFB1 stimulated A375 H3K27ac 6.11.18
- GSM6579003 TGFB1 stimulated A375 Smad2/3 6.11.18
- GSM6579004 Vehicle Control A375 INPUT 7.17.18
- GSM6579005 TGFB1 stimulated A375 INPUT 7.17.18
- GSM6579006 Vehicle Control A375 MITF 7.17.18
- GSM6579007 TGFB1 stimulated A375 MITF 7.17.18
- GSM6579008 Vehicle Control A375 Input 11.18.20
- GSM6579009 TGFB1 stimulated A375 Input 11.18.20
- GSM6579010 Vehicle Control A375 ATF3 11.18.20
- GSM6579011 Vehicle Control A375 JUNB 11.18.20
- GSM6579012 TGFB1 stimulated A375 ATF3 11.18.20
- GSM6579013 TGFB1 stimulated A375 JUNB 11.18.20
- GSM6579014 Vehicle Control treated A375 Replicate 1 Vehicle Control treated…
- GSM6579015 Vehicle Control treated A375 Replicate 2 Vehicle Control treated…
- GSM6579016 Vehicle Control treated A375 Replicate 3 Vehicle Control treated…
- GSM6579017 10ng/mL TGFB1 treated A375 Replicate 1 10ng/mL TGFB1 treated A…
- GSM6579018 10ng/mL TGFB1 treated A375 Replicate 2 10ng/mL TGFB1 treated A…
- GSM6579019 10ng/mL TGFB1 treated A375 Replicate 3 10ng/mL TGFB1 treated A…
- GSM6579020 Vehicle Control treated ZMEL1 Replicate 1 Vehicle Control treated…
- GSM6579021 Vehicle Control treated ZMEL1 Replicate 2 Vehicle Control treated…
- GSM6579022 Vehicle Control treated ZMEL1 Replicate 3 Vehicle Control treated…
- GSM6579023 10ng/mL TGFB1 treated ZMEL1 Replicate 1 10ng/mL TGFB1 treated Z…
- GSM6579024 10ng/mL TGFB1 treated ZMEL1 Replicate 2 10ng/mL TGFB1 treated Z…
- GSM6579025 10ng/mL TGFB1 treated ZMEL1 Replicate 3 10ng/mL TGFB1 treated Z…
- GSM6580960 TIE:EGFP MCR:MCS Tumor 1 GFP+ #1 EGFP MCR:MCS Tumor 1 GF…
- GSM6580961 TIE:EGFP MCR:MCS Tumor 1 GFP+ #2 EGFP MCR:MCS Tumor 1 GF…
- GSM6580962 TIE:EGFP MCR:MCS Tumor 1 mCherry+;GFP-
- GSM6580963 TIE:EGFP MCR:MCS Tumor 1 GFP+ #3 EGFP MCR:MCS Tumor 1 GF…
- GSM6580964 TIE:EGFP MCR:SATB2 Tumor 1 GFP+ #1 EGFP MCR:SATB2 Tumor 1 …
- GSM6580965 TIE:EGFP MCR:SATB2 Tumor 1 GFP+ #2 EGFP MCR:SATB2 Tumor 1 …
- GSM6580966 TIE:EGFP MCR:SATB2 Tumor 1 GFP-/mCherry+
- GSM6580967 TIE:EGFP MCR:SATB2 Tumor 1 GFP+ #3 EGFP MCR:SATB2 Tumor 1 …
- GSM6580968 TIE:EGFP MCR:MCS Tumor 2 GFP+ #1 EGFP MCR:MCS Tumor 2 GF…
- GSM6580969 TIE:EGFP MCR:MCS Tumor 2 GFP+ #2 EGFP MCR:MCS Tumor 2 GF…
- GSM6580970 TIE:EGFP MCR:MCS Tumor 2 GFP-/mCherry+
- GSM6580971 TIE:EGFP MCR:MCS Tumor 2 GFP+ #3 EGFP MCR:MCS Tumor 2 GF…
- GSE134459 Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 73 samples same disease briefing · shares melanoma
- GSE12391 Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi 114 samples same disease briefing · shares melanoma
- GSE230489 RNA-sequencing of cutaneous melanoma and non-small cell lung cancer biopsies 38 samples same disease briefing · shares melanoma
- GSE100797 Mutational and neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma 25 samples same disease briefing · shares melanoma
- GSE123728 Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma 24 samples same disease briefing · shares melanoma
- GSE130956 Investigation of ST8SIA1 expression in icaritin-treated and untreated melanoma cell lines 12 samples same disease briefing · shares melanoma
- GSE140150 A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6 samples same disease briefing · shares melanoma
- GSE91061 Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy 109 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.